Literature DB >> 28919515

Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity.

Nicholas B Miner1, Josh S Elmore2, Michael H Baumann2, Tamara J Phillips3, Aaron Janowsky4.   

Abstract

Trace amine-associated receptor 1 (TAAR1) is activated by methamphetamine (MA) and modulates dopaminergic (DA) function. Although DA dysregulation is the hallmark of MA-induced neurotoxicity leading to behavioral and cognitive deficits, the intermediary role of TAAR1 has yet to be characterized. To investigate TAAR1 regulation of MA-induced neurotoxicity, Taar1 transgenic knock-out (KO) and wildtype (WT) mice were administered saline or a neurotoxic regimen of 4 i.p. injections, 2h apart, of MA (2.5, 5, or 10mg/kg). Temperature data were recorded during the treatment day. Additionally, striatal tissue was collected 2 or 7days following MA administration for analysis of DA, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and tyrosine hydroxylase (TH) levels, as well as glial fibrillary acidic protein (GFAP) expression. MA elicited an acute hypothermic drop in body temperature in Taar1-WT mice, but not in Taar1-KO mice. Two days following treatment, DA and TH levels were lower in Taar1-KO mice compared to Taar1-WT mice, regardless of treatment, and were dose-dependently decreased by MA. GFAP expression was significantly increased by all doses of MA at both time points and greater in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5mg/kg. Seven days later, DA levels were decreased in a similar pattern: DA was significantly lower in Taar1-KO compared to Taar1-WT mice receiving MA 2.5 or 5mg/kg. TH levels were uniformly decreased by MA, regardless of genotype. These results indicate that activation of TAAR1 potentiates MA-induced hypothermia and TAAR1 confers sustained neuroprotection dependent on its thermoregulatory effects. Published by Elsevier B.V.

Entities:  

Keywords:  Dopamine; GFAP; Methamphetamine; Neurotoxicity; TAAR1; Temperature

Mesh:

Substances:

Year:  2017        PMID: 28919515      PMCID: PMC5683899          DOI: 10.1016/j.neuro.2017.09.006

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  92 in total

1.  Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6.

Authors:  B Ladenheim; I N Krasnova; X Deng; J M Oyler; A Polettini; T H Moran; M A Huestis; J L Cadet
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

Review 2.  New insights into the mechanism of action of amphetamines.

Authors:  Annette E Fleckenstein; Trent J Volz; Evan L Riddle; James W Gibb; Glen R Hanson
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.

Authors:  John H Anneken; Mariana Angoa-Pérez; Donald M Kuhn
Journal:  J Neurochem       Date:  2015-03-02       Impact factor: 5.372

4.  Health conditions in methamphetamine-dependent adults 3 years after treatment.

Authors:  Larissa J Mooney; Suzette Glasner-Edwards; Patricia Marinelli-Casey; Maureen Hillhouse; Alfonso Ang; Jeremy Hunter; William Haning; Paula Colescott; Walter Ling; Richard Rawson
Journal:  J Addict Med       Date:  2009-09       Impact factor: 3.702

5.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Authors:  J R Bunzow; M S Sonders; S Arttamangkul; L M Harrison; G Zhang; D I Quigley; T Darland; K L Suchland; S Pasumamula; J L Kennedy; S B Olson; R E Magenis; S G Amara; D K Grandy
Journal:  Mol Pharmacol       Date:  2001-12       Impact factor: 4.436

6.  Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain.

Authors:  Lin Zhang; Yukihiko Shirayama; Eiji Shimizu; Masaomi Iyo; Kenji Hashimoto
Journal:  Eur J Pharmacol       Date:  2006-06-03       Impact factor: 4.432

7.  Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia.

Authors:  S E Shortall; A R Green; K M Swift; K C F Fone; M V King
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

8.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

9.  Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?

Authors:  Krishnan Sriram; Stanley A Benkovic; Meleik A Hebert; Diane B Miller; James P O'Callaghan
Journal:  J Biol Chem       Date:  2004-03-02       Impact factor: 5.157

10.  A Mouse Model for Binge-Level Methamphetamine Use.

Authors:  Shkelzen Shabani; Sydney K Houlton; Laura Hellmuth; Erika Mojica; John R K Mootz; Zhen Zhu; Cheryl Reed; Tamara J Phillips
Journal:  Front Neurosci       Date:  2016-11-02       Impact factor: 4.677

View more
  16 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

2.  Differential genetic risk for methamphetamine intake confers differential sensitivity to the temperature-altering effects of other addictive drugs.

Authors:  John R K Mootz; Nicholas B Miner; Tamara J Phillips
Journal:  Genes Brain Behav       Date:  2020-01-15       Impact factor: 3.449

Review 3.  TAAR1 and Psychostimulant Addiction.

Authors:  Jianfeng Liu; Ruyan Wu; Jun-Xu Li
Journal:  Cell Mol Neurobiol       Date:  2020-01-23       Impact factor: 5.046

4.  5' UTR variants in the quantitative trait gene Hnrnph1 support reduced 5' UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity.

Authors:  Qiu T Ruan; Neema Yazdani; Eric R Reed; Jacob A Beierle; Lucy P Peterson; Kimberly P Luttik; Karen K Szumlinski; William E Johnson; Peter E A Ash; Benjamin Wolozin; Camron D Bryant
Journal:  FASEB J       Date:  2020-05-13       Impact factor: 5.191

5.  Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2.

Authors:  Xiao Shi; Tracy L Swanson; Nicholas B Miner; Amy J Eshleman; Aaron Janowsky
Journal:  Mol Pharmacol       Date:  2019-08-13       Impact factor: 4.436

6.  The Role of Biogenic Amine Transporters in Trace Amine-Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity.

Authors:  Nicholas B Miner; Tamara J Phillips; Aaron Janowsky
Journal:  J Pharmacol Exp Ther       Date:  2019-07-18       Impact factor: 4.030

Review 7.  Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.

Authors:  Ruyan Wu; Jun-Xu Li
Journal:  CNS Drugs       Date:  2021-11-12       Impact factor: 5.749

Review 8.  Combined and sequential effects of alcohol and methamphetamine in animal models.

Authors:  Alexandra M Stafford; Bryan K Yamamoto; Tamara J Phillips
Journal:  Neurosci Biobehav Rev       Date:  2021-09-17       Impact factor: 8.989

9.  Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward.

Authors:  Jacob A Beierle; Emily J Yao; Stanley I Goldstein; William B Lynch; Julia L Scotellaro; Anyaa A Shah; Katherine D Sena; Alyssa L Wong; Colton L Linnertz; Olga Averin; David E Moody; Christopher A Reilly; Gary Peltz; Andrew Emili; Martin T Ferris; Camron D Bryant
Journal:  J Pharmacol Exp Ther       Date:  2022-06-10       Impact factor: 4.402

10.  Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake.

Authors:  Shkelzen Shabani; Bryan Schmidt; Bikalpa Ghimire; Sydney K Houlton; Laura Hellmuth; Erika Mojica; Tamara J Phillips
Journal:  Genes Brain Behav       Date:  2018-11-26       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.